文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

减重手术患者肝病患病率及结局:180,544例分析

Characterizing liver disease in patients undergoing bariatric surgery: Prevalence and outcomes of 180,544 cases.
PubMed 文献 · Surgery · 2025-12-12

基于2023年MBSAQIP数据库180,544例初次腹腔镜和机器人减重手术患者的回顾性分析,肝病患病率为11.5%。

要点

  • 减重手术患者中肝病患病率为11.5%(20,678/180,544)。
  • 肝病独立增加30天严重并发症风险(OR 1.18,95%CI 1.09-1.29)。

核心结论

  • 肝病在减重手术患者中常见,独立关联围术期并发症增加但不增加死亡率。

研究设计与样本

  • 回顾性分析2023年MBSAQIP数据库中180,544例初次腹腔镜和机器人减重手术患者,按有无肝病分层。

主要发现

  • 肝病组年龄更大(43.8±11.9 vs 42.9±11.9岁),女性比例更低(79.4% vs 82.5%),糖尿病(31.9% vs 22.5%)、高血压(48.1% vs 43.1%)和睡眠呼吸暂停(47.9% vs 36.9%)发生率更高(均P<.0001)。
  • 肝病组吻合口漏(0.3% vs 0.2%,P=.009)、出血(1.2% vs 0.8%,P<.0001)、再手术(1.0% vs 0.8%,P=.001)和非手术再干预(0.8% vs 0.6%,P<.0001)发生率均更高。
  • 肝病组总体严重并发症更高(3.1% vs 2.4%,P<.0001),但死亡率无差异(0.07%,P=.855)。
  • 多变量分析中肝病独立预测严重并发症(OR 1.18;95%CI 1.09-1.29;P<.0001)。

临床怎么用

  • 对合并肝病的减重手术患者应加强围术期管理以降低并发症风险。
  • 肝病不应作为减重手术的排除因素,因长期获益可能大于短期风险。

局限性

  • 数据库缺乏肝病严重程度的细化信息,无法按严重程度分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of liver disease on perioperative outcomes in bariatric surgery remains incompletely characterized. This study aims to determine the prevalence and outcomes of liver disease in patients who undergo bariatric surgery. METHODS: We conducted a retrospective analysis of 180,544 patients who underwent primary laparoscopic and robotic bariatric surgery in the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. Patients were stratified by presence of documented liver disease. Primary outcomes included 30-day complications and mortality. Multivariable logistic regression identified independent predictors of serious complications. RESULTS: Liver disease was present in 20,678 (11.5%) patients. Compared with patients without liver disease, those with liver disease were older (43.8 ±11.9 vs 42.9 ±11.9 years), less likely to be female (79.4% vs 82.5%), and had greater rates of diabetes (31.9% vs 22.5%), hypertension (48.1% vs 43.1%), and sleep apnea (47.9% vs 36.9%) (all P < .0001). Patients with liver disease experienced greater rates of anastomotic leak (0.3% vs 0.2%, P = .009), bleeding (1.2% vs 0.8%, P < .0001), reoperation (1.0% vs 0.8%, P = .001), and nonoperative reintervention (0.8% vs 0.6%, P < .0001). Overall serious complications were greater in the liver disease group (3.1% vs 2.4%, P < .0001), but mortality remained equivalent (0.07%, P = .855). On multivariable analysis, liver disease independently predicted serious complications (odds ratio, 1.18; 95% confidence interval, 1.09-1.29; P < .0001). CONCLUSION: Liver disease is common among patients who undergo bariatric surgery and independently associated with increased perioperative complications but not mortality. Although the database lacks granular liver disease characterization preventing stratification by severity despite these short-term risks, bariatric surgery remains important for patients with liver disease, who-with specialized perioperative management-stand to gain significant long-term protection against disease progression.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Wills MV, Mocanu V, Elamin D, et al. Characterizing liver disease in patients undergoing bariatric surgery: Prevalence and outcomes of 180,544 cases. Surgery. 2025. PMID: 41390246. doi:10.1016/j.surg.2025.109966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。